ZIBA NASERI: Open Payments
NPI 1396140380 · HERMITAGE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,079 in 188 payments from 18 companies in 2025. Trend: 2023 $4,874 · 2024 $4,853 · 2025 $4,079
Food & beverage: $3,933Education: $147
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 36 | $985 |
| ABBVIE INC. | 53 | $820 |
| UCB, Inc. | 26 | $508 |
| Amgen Inc. | 21 | $500 |
| Janssen Scientific Affairs, LLC | 2 | $277 |
| E.R. Squibb & Sons, L.L.C. | 10 | $156 |
| PFIZER INC. | 9 | $143 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $135 |
| Lilly USA, LLC | 4 | $116 |
| AstraZeneca Pharmaceuticals LP | 5 | $113 |
Products named: TREMFYA, RINVOQ, Bimzelx, SKYRIZI, ENBREL, ORENCIA, XELJANZ, SAPHNELO.
Industry payments across PA — which companies pay providers there.
